ARCL Organics Share Price & Earnings Call Analysis

₹212.00+0.00% today
Market cap
₹170 Cr
P/E
17.72
ROE
6.93%
PEG
-0.82
Price to sales
0.63
Debt to equity
0.86
52W high / low
₹416 / ₹151
Sales growth (5Y)
25.73%
EBITDA margin
12.44%
Net profit margin
2.03%
Promoter holding
69.22%
Sales (last year)
₹272 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Financials of ARCL Organics

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of ARCL Organics

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +46.4441.5843.2548.3357.5759.9356.4661.9672.2467.3486.1953.4765.31
Expenses +40.1238.4239.5141.2052.2754.1451.1958.1463.2960.8774.7753.7958.22
Operating Profit6.323.163.747.135.305.795.273.828.956.4711.42-0.327.09
OPM %13.61%7.60%8.65%14.75%9.21%9.66%9.33%6.17%12.39%9.61%13.25%-0.60%10.86%
Other Income +2.250.430.640.810.820.410.710.830.400.831.180.590.78
Interest0.510.510.691.390.481.081.080.981.070.990.841.381.75
Depreciation1.301.331.291.170.501.371.131.291.421.391.491.511.63
Profit before tax6.761.752.405.385.143.753.772.386.864.9210.27-2.624.49
Tax %74.26%-12.00%47.92%29.37%1.95%26.13%42.44%24.37%18.51%18.70%29.70%236.26%37.86%
Net Profit +1.741.961.253.805.042.772.181.795.603.997.22-8.812.79
EPS in Rs2.182.451.564.756.303.462.722.247.004.999.02-11.013.49

Financials of ARCL Organics

Profit & Loss

Annual income statement trend

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +717187141165191251272
Expenses +676474126147171227248
Operating Profit47121518192425
OPM %6%9%14%11%11%10%10%9%
Other Income +11223323
Interest23212345
Depreciation11113456
Profit before tax13111517151717
Tax %26%24%28%29%30%23%26%70%
Net Profit +138111211125
EPS in Rs1.393.1510.0513.1614.5914.1215.416.49
Dividend Payout %0%0%0%0%0%0%0%0%

Financials of ARCL Organics

Balance Sheet

Capital structure and asset base

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital88888888
Reserves1416243546586974
Borrowings +201791520293471
Other Liabilities +1513274146635767
Total Liabilities57556898120157169220
Fixed Assets +2221202746636897
CWIP00000000
Investments00000000
Other Assets +353448717494101123
Total Assets57556898120157169220

Financials of ARCL Organics

Cash Flows

Operating, investing and financing cash movement

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-266225135-4
Cash from Investing Activity +-4-0-1-7-22-21-9-34
Cash from Financing Activity +7-5-4547232
Net Cash Flow001-17-1-2-5
Free Cash Flow-755-63-8-5-39
CFO/OP-55%90%60%26%152%66%22%-7%

Financials of ARCL Organics

Ratios

Working capital efficiency and return ratios

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days8787968271667556
Inventory Days3545404338582845
Days Payable514389881051309079
Cash Conversion Cycle718948374-61422
Working Capital Days23248411619212
ROCE %15%32%33%28%21%20%17%

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv